04:27:36 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-05-10 Ordinarie utdelning REDS 0.00 SEK
2024-05-08 Kvartalsrapport 2024-Q1
2024-05-08 Årsstämma 2024
2024-02-27 Bokslutskommuniké 2023
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-29 Kvartalsrapport 2023-Q2
2023-05-10 Ordinarie utdelning REDS 0.00 SEK
2023-05-09 Kvartalsrapport 2023-Q1
2023-05-09 Årsstämma 2023
2023-02-27 Bokslutskommuniké 2022
2022-11-09 Kvartalsrapport 2022-Q3
2022-08-29 Kvartalsrapport 2022-Q2
2022-05-03 Ordinarie utdelning REDS 0.00 SEK
2022-05-02 Årsstämma 2022
2022-05-02 Kvartalsrapport 2022-Q1
2022-02-28 Bokslutskommuniké 2021
2021-11-09 Kvartalsrapport 2021-Q3
2021-08-24 Kvartalsrapport 2021-Q2
2021-05-12 Årsstämma 2021
2021-05-05 Ordinarie utdelning REDS 0.00 SEK
2021-05-03 Kvartalsrapport 2021-Q1
2021-04-19 Extra Bolagsstämma 2021
2021-02-28 Bokslutskommuniké 2020
2020-12-18 Extra Bolagsstämma 2020
2020-11-09 Kvartalsrapport 2020-Q3
2020-08-24 Kvartalsrapport 2020-Q2
2020-06-23 Ordinarie utdelning REDS 0.00 SEK
2020-06-22 Årsstämma 2020
2020-05-04 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019
2019-11-18 Kvartalsrapport 2019-Q3
2019-08-26 Kvartalsrapport 2019-Q2
2019-05-07 Ordinarie utdelning REDS 0.00 SEK
2019-05-06 Årsstämma 2019
2019-05-06 Kvartalsrapport 2019-Q1
2019-02-26 Bokslutskommuniké 2018
2018-08-27 Kvartalsrapport 2018-Q2
2018-05-08 Ordinarie utdelning REDS 0.00 SEK
2018-05-07 Årsstämma 2018
2018-02-27 Bokslutskommuniké 2017
2017-09-25 Extra Bolagsstämma 2017
2017-08-28 Kvartalsrapport 2017-Q2
2017-04-06 Ordinarie utdelning REDS 0.00 SEK
2017-04-05 Årsstämma 2017
2017-02-22 Bokslutskommuniké 2016
2016-10-26 Kvartalsrapport 2016-Q3
2016-08-25 Kvartalsrapport 2016-Q2
2016-05-09 Årsstämma 2016
2016-05-09 Kvartalsrapport 2016-Q1
2016-02-23 Ordinarie utdelning REDS 0.00 SEK
2016-02-22 Bokslutskommuniké 2015
2015-11-27 Kvartalsrapport 2015-Q3

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Redsense Medical är ett medicinteknikbolag som är specialiserat inom utvecklingen av blodläckage-alarm. Bolagets produkt fungerar som en sensor baserad på fiberteknik som snabbare skall upptäcka blodförlust, samt larma och rapportera till olika larmenheter. Utöver huvudverksamheten erbjuds träning och utbildning inom affärsområdet. Bolaget grundades år 2006 och har sitt huvudkontor i Halmstad.
2024-03-14 16:30:00

On March 12, 2024, the House Committee on Ways and Means Chairman Jason Smith (MO-08) held a Hearing to examine opportunities and challenges in enhancing access to care in patients' home and modernizing care in rural and underserved communities.

The Hearing was titled, "Enhancing Access to Care at Home in Rural and Underserved Communities." and during the Hearing Rep. Adrian Smith (NE-03) made the following remarks:

"Thank you to all our witnesses for joining us today to talk about this important topic. It is amazing to see how new technologies have expanded the boundaries of access to health care. Every day we see new devices which allow services that could previously only be performed in the hospital to be accessed from home.  Even though telehealth has made it easier than ever for patients to connect with their providers, it is innovation in medical devices that has most dramatically expanded the ability of patients to safely receive care in their homes."

"But lack of adequate Medicare coverage can often create roadblocks to adoption of new technologies that expand safe home access to care.

That's why I introduced the Home Dialysis Risk Prevention Act (H.R.3118), which would reduce the risk home hemodialysis patients face of serious complications from venous needle dislodgement. This legislation would ensure adequate Medicare reimbursement for the sensors and alarms that can detect when the blood return needle slips loose, putting a patient at risk of serious blood loss or death.

"I hope today's conversation leads to further legislative action on removing outdated regulatory and statutory barriers to accessing these new and revolutionary technologies for greater access to care in our homes."

The Home Hemodialysis Risk Prevention Act (H.R. 3118) is a bipartisan legislation which aims to provide Medicare coverage for blood loss monitoring and detection devices. The bill is sponsored by Rep. Adrian Smith (R-NE) and Rep. Melanie Stansbury (D-NM).

"We are very pleased that US House of Representatives is addressing patient safety for hemodialysis at home with this this important legislation. This is in line with Redsense's focus to provide increased patient safety for home hemodialysis. We look forward to the advancement of this bill." says Pontus Nobréus, CEO of Redsense Medical.